Inhaled hydrogen gas therapy for prevention of noise-induced hearing loss through reducing reactive oxygen species.
Takaomi Kurioka, Takeshi Matsunobu, Yasushi Satoh, Katsuki Niwa, Akihiro Shiotani · Neuroscience research · 2014
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In guinea pigs, strong immunoreactivities against 8-OHdG were observed of the non-treated group, the H₂-treated group showed decreased immunoreactivity for 8-OHdG. These results are preclinical and suggest molecular hydrogen's therapeutic potential in the condition studied. Further human research is needed to establish clinical effectiveness.
What the Researchers Studied
Guinea pigs
How Molecular Hydrogen Was Used
These findings strongly suggest that inhaled hydrogen gas protects against NIHL.
What the Researchers Found
Strong immunoreactivities against 8-OHdG were observed of the non-treated group, the H₂-treated group showed decreased immunoreactivity for 8-OHdG.
Authors’ Conclusion
The authors concluded that these findings strongly suggest that inhaled hydrogen gas protects against NIHL. These results are preclinical and suggest molecular hydrogen's therapeutic potential in the condition studied. Further human research is needed to establish clinical effectiveness.